Health economics has been a long-standing focus of attention at IFE Baltic UAB. We closely cooperate with health care providers, pharmaceutical companies, medical device companies and third-party payers, including sick funds and governmental institutions, to develop and introduce new concepts of health care. Previous health economic projects include:

Commercial opportunity assessment and estimation of market potential, related to the therapeutic
areas in R&D, and marketing & sales, as well as to specific projects
Development of health economic documentation for procedures and products in the development,
pre-marketing and marketing phase of their life cycle
Support of pricing decisions by identifying acceptable price ranges for new products
Economic comparison of alternative treatment modalities
Economic evaluation of disease and case management concepts
De novo generation of health economic data.

These tasks were approached by means of e.g.:

strategic assistance
clinical trial, piggy-back study, randomised post-marketing surveillances, cost-effectiveness analysis, cost-benefit analysis, cost-utility analysis, cost-minimisation analysis, quality-of-life analysis, cross-design

planning
choice of study design, retrospective or prospective study

method
meta-analysis, clinical data modelling: Markov-type model and decision-analysis, incremental analysis, sensitivity analysis, discounting

execution
according to relevant guidelines, study report, quality assurance, interpretation and valuation

elaboration of marketing strategies